Saeed Alshahrani

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Candida Albicans

Metal Organic Framework

Prostate Cancer

Top Venues

Molecules (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Saeed Alshahrani, Abdullah Mohammed Al-Majid, Abdullah Saleh Alamary, Mohamed Ali, Mezna Saleh Altowyan, Mar Ríos-Gutiérrez, Sammer Yousuf, Assem Barakat
Synthesis and Characterization of New Spirooxindoles Including Triazole and Benzimidazole Pharmacophores via [3+2] Cycloaddition Reaction: An MEDT Study of the Mechanism and Selectivity. Molecules (Basel, Switzerland) 28 (19) (2023)
Assem Barakat, Saeed Alshahrani, Abdullah Mohammed Al-Majid, Abdullah Saleh Alamary, Matti Haukka, Marwa M Abu-Serie, Luis R Domingo, Sajda Ashraf, Zaheer Ul Haq, Mohamed S Nafie, Mohamed Teleb
New spiro-indeno[1,2- b ]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Abdullah Mohammed Al-Majid, Abdullah Saleh Alammari, Saeed Alshahrani, Matti Haukka, Mohammad Shahidul Islam, Assem Barakat
Cu(ii)-thiophene-2,5-bis(amino-alcohol) mediated asymmetric Aldol reaction and Domino Knoevenagel Michael cyclization: a new highly efficient Lewis acid catalyst. RSC advances 12 (10) (2022)
Mohammad Shahidul Islam, Abdullah Saleh Alamary, Assem Barakat, Saeed Alshahrani, Matti Haukka, Abdullah Mohammed Al-Majid
Exploiting the Chiral Ligands of Bis(imidazolinyl)- and Bis(oxazolinyl)thiophenes-Synthesis and Application in Cu-Catalyzed Friedel-Crafts Asymmetric Alkylation. Molecules (Basel, Switzerland) 26 (23) (2021)
Abdullah Mohammed Al-Majid, Mohamed Ali, Mohammad Shahidul Islam, Saeed Alshahrani, Abdullah Saleh Alamary, Sammer Yousuf, M Iqbal Choudhary, Assem Barakat
Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents. Molecules (Basel, Switzerland) 26 (20) (2021)